Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies
Số trang: 13
Loại file: pdf
Dung lượng: 1.15 MB
Lượt xem: 14
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
For drugs reimbursed with limited evidence of patient benefits, confirmatory evidence of overall survival (OS) and quality of life (QoL) benefits is important. For QoL data to serve as valuable input to patients and decisionmakers, it must be measured and analyzed using appropriate methods. We aimed to assess the measurement and analyses of post-reimbursement QoL data for cancer drugs introduced in Swedish healthcare with limited evidence at the time of reimbursement.
Nội dung trích xuất từ tài liệu:
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies
Nội dung trích xuất từ tài liệu:
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Health-related quality of life Patient-reported outcomes Randomized controlled trials Quality assessment Swedish healthcareGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 117 0 0 -
12 trang 92 0 0
-
19 trang 74 0 0
-
17 trang 63 0 0
-
9 trang 41 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0